| Secondary |
| Type 2 Diabetes Mellitus |
19.8% |
| Hypertension |
16.0% |
| Diabetes Mellitus |
15.1% |
| Drug Use For Unknown Indication |
12.3% |
| Product Used For Unknown Indication |
8.5% |
| Thrombosis Prophylaxis |
5.7% |
| Dyslipidaemia |
2.8% |
| Hyperuricaemia |
2.8% |
| Tooth Abscess |
2.8% |
| Back Pain |
1.9% |
| Benign Prostatic Hyperplasia |
1.9% |
| Oropharyngeal Gonococcal Infection |
1.9% |
| Prophylaxis |
1.9% |
| Bone Pain |
0.9% |
| Diabetes Mellitus Non-insulin-dependent |
0.9% |
| Gastric Ulcer |
0.9% |
| Hepatitis B |
0.9% |
| Infection |
0.9% |
| Intentional Self-injury |
0.9% |
| Psoriasis |
0.9% |
|
| Renal Failure Acute |
22.2% |
| Hypoglycaemia |
18.5% |
| Fall |
7.4% |
| International Normalised Ratio Increased |
7.4% |
| Rhabdomyolysis |
7.4% |
| Hemianopia |
3.7% |
| Hepatitis Fulminant |
3.7% |
| Hypoglycaemic Coma |
3.7% |
| Lung Neoplasm Malignant |
3.7% |
| Malaise |
3.7% |
| Pancreatitis Acute |
3.7% |
| Self Injurious Behaviour |
3.7% |
| Sopor |
3.7% |
| Thrombocytopenia |
3.7% |
| Weight Increased |
3.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.7% |
| Hypertension |
13.8% |
| Product Used For Unknown Indication |
12.9% |
| Diabetes Mellitus |
12.1% |
| Type 2 Diabetes Mellitus |
6.3% |
| Prophylaxis |
4.9% |
| Rheumatoid Arthritis |
4.0% |
| Cardiomyopathy |
3.3% |
| Non-hodgkin's Lymphoma |
3.3% |
| Atrial Fibrillation |
2.9% |
| Coronary Artery Disease |
2.9% |
| B-cell Lymphoma |
1.8% |
| Schizoaffective Disorder |
1.8% |
| Hypercholesterolaemia |
1.6% |
| Arthralgia |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
| Depression |
1.3% |
| Gastritis |
1.3% |
| Hypertriglyceridaemia |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
|
| Coeliac Disease |
8.6% |
| Renal Failure |
8.6% |
| Vomiting |
8.6% |
| Transient Ischaemic Attack |
7.1% |
| Osteonecrosis |
5.7% |
| Blood Glucose Increased |
4.3% |
| Hypoglycaemia |
4.3% |
| Hypoglycaemic Coma |
4.3% |
| Hypotension |
4.3% |
| International Normalised Ratio Increased |
4.3% |
| Lymphopenia |
4.3% |
| Presyncope |
4.3% |
| Pulmonary Oedema |
4.3% |
| Renal Failure Acute |
4.3% |
| Skin Ulcer Haemorrhage |
4.3% |
| Sopor |
4.3% |
| Torsade De Pointes |
4.3% |
| Toxic Skin Eruption |
4.3% |
| Arthritis |
2.9% |
| Asthenia |
2.9% |
|
| Interacting |
| Cardiomyopathy |
60.0% |
| Infection |
20.0% |
| Type 2 Diabetes Mellitus |
20.0% |
|
|
